6-methyl-2-ethyl-3-hydroxypyridine has been researched along with 5-ethoxy-2-ethylmercaptobenzimidazole in 1 studies
Studies (6-methyl-2-ethyl-3-hydroxypyridine) | Trials (6-methyl-2-ethyl-3-hydroxypyridine) | Recent Studies (post-2010) (6-methyl-2-ethyl-3-hydroxypyridine) | Studies (5-ethoxy-2-ethylmercaptobenzimidazole) | Trials (5-ethoxy-2-ethylmercaptobenzimidazole) | Recent Studies (post-2010) (5-ethoxy-2-ethylmercaptobenzimidazole) |
---|---|---|---|---|---|
166 | 24 | 33 | 21 | 0 | 3 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kobzeva, EA; Plotnikov, MB; Plotnikova, TM | 1 |
1 other study(ies) available for 6-methyl-2-ethyl-3-hydroxypyridine and 5-ethoxy-2-ethylmercaptobenzimidazole
Article | Year |
---|---|
[Antioxidant effects of antihypoxic drugs in cerebral ischemia].
Topics: Animals; Antioxidants; Arterial Occlusive Diseases; Benzimidazoles; Brain Ischemia; Carotid Artery Diseases; Picolines; Rats; Rats, Wistar; Sodium Oxybate | 1992 |